GLAXOSMITHKLINE PLC | CIK:0001131399 | 3

  • Filed: 3/20/2018
  • Entity registrant name: GLAXOSMITHKLINE PLC (CIK: 0001131399)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/0001193125-18-088407-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/gsk-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001131399
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfCommitmentsExplanatory

    41. Commitments

     

         2017          2016  

    Contractual obligations and commitments

       £m          £m  

    Contracted for but not provided in the financial statements:

           

    Intangible assets

         5,254          7,199  

    Property, plant and equipment

         584          496  

    Investments

         107          166  

    Purchase commitments

         346          52  

    Pensions

         738          874  

    Other commitments

         38          143  

    Interest on loans

         8,510          9,410  

    Finance lease charges

         12          3  
      

     

     

          

     

     

     
         15,589          18,343  
      

     

     

          

     

     

     

    The commitments related to intangible assets include milestone payments, which are dependent on successful clinical development or on meeting specified sales targets, and which represent the maximum that would be paid if all milestones, however unlikely, are achieved. The amounts are not risk-adjusted or discounted. The decrease in intangible commitments in 2017 is attributable to amendments made to the agreement with Adaptimmune Therapeutics plc and reduction in commitments to third parties such as Ionis Pharmaceuticals, Inc.

    In 2016, GSK reached an agreement with the trustees of the UK pension schemes to make additional contributions to eliminate the pension deficit identified at the 31 December 2014 actuarial funding valuation. A payment of £123 million is due in 2018 and each subsequent year up to, and including 2023. The table above includes this commitment, but excludes the normal ongoing annual funding requirement in the UK of approximately £130 million.

    The Group also has other commitments which principally relate to revenue payments to be made under licences and other alliances.

    Commitments in respect of future interest payable on loans are disclosed before taking into account the effect of interest rate swaps.

    Commitments under non-cancellable operating leases are disclosed below. £117 million (2016 – £186 million) is provided against these commitments on the Group’s balance sheet.

     

         2017          2016  

    Commitments under non-cancellable operating leases

       £m          £m  

    Rental payments due within one year

         186          153  

    Rental payments due between one and two years

         149          129  

    Rental payments due between two and three years

         122          94  

    Rental payments due between three and four years

         107          74  

    Rental payments due between four and five years

         94          66  

    Rental payments due after five years

         387          324  
      

     

     

          

     

     

     

    Total commitments under non-cancellable operating leases

         1,045          840